News & Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Radiation Oncology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Northwestern Medicine investigators have revealed new insights into how cell type switches facilitate tumor growth and treatment resistance in small cell lung cancer, according to findings published in Science Advances.
Dozens of faculty members and fourth-year medical students were recognized for their scholarly and clinical excellence at Feinberg’s Honors Day, held May 20.
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
Fourth-year medical students were honored for their clinical and academic achievements at a virtual Graduate Recognition Ceremony on May 21.
An experimental spherical nucleic acid drug developed by Northwestern scientists was able to penetrate the blood-brain barrier and trigger the death of glioblastoma cells.
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
A new method of delivering radiation during whole brain radiotherapy could reduce neurotoxicity without compromising effectiveness, according to a new study.
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
Feinberg graduating medical students and faculty members were recognized for their academic and teaching excellence at the seventh annual Honors Day celebration.
Medical student Liam Kane discusses his orthopaedic surgery research fellowship, his interest in global health and what he loves about Feinberg.
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing and tissue repair after heart attack, in a study published in Cell Metabolism.
Students, faculty and alumni gathered for the seventh annual Driskill Day, celebrating the Driskill Graduate Program in Life Sciences by welcoming 28 new students and showcasing the program’s strengths in scholarship and scientific investigation.
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
Feinberg faculty and fourth-year medical students gathered to recognize clinical and academic achievement at the sixth annual Honors Day, held May 19.
Members of the class of 2017 joined faculty, friends and family members at the 158th commencement ceremony on May 22.
Feinberg faculty members and fourth-year medical students were recognized for their achievements at the fifth annual Honors Day ceremony.
Northwestern Medicine scientists have developed a novel testing platform to assess, in real time, the efficacy of nanomaterials in regulating gene expression.
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
Second-year medical students presented their in-progress research projects at the Area of Scholarly Concentration poster session.
Fourth-year medical students and faculty members were recognized for their academic achievements and teaching at the fourth annual Honors Day celebration, on May 20.
Students and faculty were recognized for their accomplishments and teaching at the Third Annual Honors Day celebration.
David Gius, MD, PhD, professor in Radiation Oncology and Pharmacology, collaborated with University of Chicago scientists on a study identifying a natural compound that activates the protein SIRT3, a potential target for breast cancer, cardiac conditions and other diseases.
Students and faculty learned how practicing mindfulness, incorporating patient spirituality and advocating for scientific research in public policy can improve patient care – and their own wellbeing as healthcare providers – during three special lecture events.
Prostate cancer cells producing too much PIM1 are particularly sensitive to the inhibition of a protein called polo-like kinase (PLK1).
Gayle E. Woloschak, PhD, professor in Radiation Oncology and Radiology, developed a new x-ray microscopy instrument that allows her to track nanoparticles in the nucleus of cancer cells, where they can do the most damage.
The 27 awards presented at the Second Annual Honors Day acknowledged senior medical students for their outstanding academic achievement and faculty members for their contributions to education.
Published in Nature Neuroscience, the findings offer a promising route for developing new treatment options in Parkinson’s disease.